| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | ZNF346 TRAF5 TRAF6 ZNF276 THRB ADAMTS9 KDM5A RCHY1 NFXL1 FBXO11 ADAM30 EP300 ZRANB3 | 2.29e-06 | 891 | 61 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | ZNF346 TRAF5 TRAF6 ZNF276 THRB ADAMTS9 KDM5A RCHY1 NFXL1 FBXO11 ADAM30 EP300 ZRANB3 | 4.99e-05 | 1189 | 61 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | hormone binding | 2.78e-04 | 103 | 61 | 4 | GO:0042562 | |
| GeneOntologyBiologicalProcess | limb development | 4.71e-05 | 224 | 60 | 6 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.71e-05 | 224 | 60 | 6 | GO:0048736 | |
| GeneOntologyBiologicalProcess | negative regulation of female receptivity | 4.97e-05 | 4 | 60 | 2 | GO:0007621 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | VEGFC FRAS1 TRAF6 FBN2 THRB EGFR ADAMTS9 ITGA6 LRP5 TECTA USH2A EP300 NOTCH2 | 5.82e-05 | 1269 | 60 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 7.07e-05 | 148 | 60 | 5 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 7.07e-05 | 148 | 60 | 5 | GO:0035113 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 8.27e-05 | 5 | 60 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 2.01e-04 | 185 | 60 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 2.01e-04 | 185 | 60 | 5 | GO:0035108 | |
| GeneOntologyCellularComponent | receptor complex | 5.08e-05 | 581 | 62 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | FACT complex | 5.17e-05 | 4 | 62 | 2 | GO:0035101 | |
| GeneOntologyCellularComponent | nuclear replication fork | 2.63e-04 | 42 | 62 | 3 | GO:0043596 | |
| GeneOntologyCellularComponent | CD40 receptor complex | 4.68e-04 | 11 | 62 | 2 | GO:0035631 | |
| GeneOntologyCellularComponent | MCM complex | 4.68e-04 | 11 | 62 | 2 | GO:0042555 | |
| Domain | EGF-like_dom | 7.36e-09 | 249 | 61 | 10 | IPR000742 | |
| Domain | EGF | 6.66e-08 | 235 | 61 | 9 | SM00181 | |
| Domain | EGF_3 | 9.25e-07 | 235 | 61 | 8 | PS50026 | |
| Domain | EGF_1 | 1.71e-06 | 255 | 61 | 8 | PS00022 | |
| Domain | EGF-like_CS | 2.03e-06 | 261 | 61 | 8 | IPR013032 | |
| Domain | EGF_2 | 2.27e-06 | 265 | 61 | 8 | PS01186 | |
| Domain | EGF-like_Ca-bd_dom | 3.12e-06 | 124 | 61 | 6 | IPR001881 | |
| Domain | EGF | 3.43e-06 | 126 | 61 | 6 | PF00008 | |
| Domain | APPLE | 1.05e-05 | 2 | 61 | 2 | SM00223 | |
| Domain | APPLE | 1.05e-05 | 2 | 61 | 2 | PS00495 | |
| Domain | Apple | 1.05e-05 | 2 | 61 | 2 | IPR000177 | |
| Domain | Growth_fac_rcpt_ | 1.17e-05 | 156 | 61 | 6 | IPR009030 | |
| Domain | Ldl_recept_b | 1.18e-05 | 14 | 61 | 3 | PF00058 | |
| Domain | LDLRB | 1.18e-05 | 14 | 61 | 3 | PS51120 | |
| Domain | LY | 1.47e-05 | 15 | 61 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.47e-05 | 15 | 61 | 3 | IPR000033 | |
| Domain | EGF_CA | 1.78e-05 | 99 | 61 | 5 | PS01187 | |
| Domain | EGF_CA | 4.86e-05 | 122 | 61 | 5 | SM00179 | |
| Domain | hEGF | 1.02e-04 | 28 | 61 | 3 | PF12661 | |
| Domain | TNF_rcpt--assoc_TRAF | 1.56e-04 | 6 | 61 | 2 | IPR012227 | |
| Domain | PAN | 2.18e-04 | 7 | 61 | 2 | PS50948 | |
| Domain | Pan_app | 2.18e-04 | 7 | 61 | 2 | IPR003609 | |
| Domain | PAN_1 | 2.18e-04 | 7 | 61 | 2 | PF00024 | |
| Domain | - | 2.79e-04 | 39 | 61 | 3 | 2.120.10.30 | |
| Domain | EGF_Ca-bd_CS | 2.84e-04 | 97 | 61 | 4 | IPR018097 | |
| Domain | zf-TRAF | 2.90e-04 | 8 | 61 | 2 | PF02176 | |
| Domain | LDLR_class-A_CS | 3.00e-04 | 40 | 61 | 3 | IPR023415 | |
| Domain | ASX_HYDROXYL | 3.19e-04 | 100 | 61 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.99e-04 | 106 | 61 | 4 | IPR000152 | |
| Domain | Ldl_recept_a | 4.27e-04 | 45 | 61 | 3 | PF00057 | |
| Domain | - | 4.55e-04 | 46 | 61 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.55e-04 | 46 | 61 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 5.16e-04 | 48 | 61 | 3 | PS01209 | |
| Domain | LDLRA_2 | 5.49e-04 | 49 | 61 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 5.49e-04 | 49 | 61 | 3 | IPR002172 | |
| Domain | LDLa | 5.49e-04 | 49 | 61 | 3 | SM00192 | |
| Domain | MATH/TRAF_dom | 6.78e-04 | 12 | 61 | 2 | IPR002083 | |
| Domain | MATH | 6.78e-04 | 12 | 61 | 2 | PS50144 | |
| Domain | MATH | 6.78e-04 | 12 | 61 | 2 | SM00061 | |
| Domain | Znf_TRAF | 6.78e-04 | 12 | 61 | 2 | IPR001293 | |
| Domain | MATH | 6.78e-04 | 12 | 61 | 2 | PF00917 | |
| Domain | ZF_TRAF | 8.00e-04 | 13 | 61 | 2 | PS50145 | |
| Domain | - | 9.31e-04 | 14 | 61 | 2 | 3.90.890.10 | |
| Domain | - | 9.31e-04 | 14 | 61 | 2 | 2.60.210.10 | |
| Domain | SIAH-type | 1.22e-03 | 16 | 61 | 2 | IPR013323 | |
| Domain | Furin_repeat | 1.55e-03 | 18 | 61 | 2 | IPR006212 | |
| Domain | FU | 1.55e-03 | 18 | 61 | 2 | SM00261 | |
| Domain | VWC_out | 1.73e-03 | 19 | 61 | 2 | SM00215 | |
| Domain | TNFR_c6 | 2.32e-03 | 22 | 61 | 2 | PF00020 | |
| Domain | TRAF-like | 2.77e-03 | 24 | 61 | 2 | IPR008974 | |
| Domain | EGF_CA | 2.80e-03 | 86 | 61 | 3 | PF07645 | |
| Domain | TRYPSIN_SER | 3.18e-03 | 90 | 61 | 3 | IPR033116 | |
| Domain | TNFR | 3.24e-03 | 26 | 61 | 2 | SM00208 | |
| Domain | cEGF | 3.24e-03 | 26 | 61 | 2 | IPR026823 | |
| Domain | cEGF | 3.24e-03 | 26 | 61 | 2 | PF12662 | |
| Domain | TNFR_NGFR_1 | 4.02e-03 | 29 | 61 | 2 | PS00652 | |
| Domain | TNFR_NGFR_2 | 4.02e-03 | 29 | 61 | 2 | PS50050 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING | 2.42e-05 | 51 | 47 | 4 | M39438 | |
| Pathway | WP_CANCER_PATHWAYS | 3.77e-05 | 507 | 47 | 9 | M48302 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 9.24e-05 | 325 | 47 | 7 | M12868 | |
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 10764746 | ||
| Pubmed | 1.52e-06 | 13 | 62 | 3 | 11035039 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28263981 | ||
| Pubmed | FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. | 3.13e-06 | 2 | 62 | 2 | 21430781 | |
| Pubmed | The MMS22L-TONSL complex mediates recovery from replication stress and homologous recombination. | 3.13e-06 | 2 | 62 | 2 | 21055983 | |
| Pubmed | The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells. | 3.13e-06 | 2 | 62 | 2 | 12944405 | |
| Pubmed | MMS22L-TONSL functions in sister chromatid cohesion in a pathway parallel to DSCC1-RFC. | 3.13e-06 | 2 | 62 | 2 | 36622344 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28124063 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3636155 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21159248 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 14557654 | ||
| Pubmed | 6.02e-06 | 20 | 62 | 3 | 19862325 | ||
| Pubmed | 7.01e-06 | 21 | 62 | 3 | 18591388 | ||
| Pubmed | 8.11e-06 | 22 | 62 | 3 | 18372903 | ||
| Pubmed | 9.31e-06 | 23 | 62 | 3 | 26027930 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 23114924 | ||
| Pubmed | Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast. | 9.37e-06 | 3 | 62 | 2 | 23327061 | |
| Pubmed | Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. | 9.37e-06 | 3 | 62 | 2 | 7618084 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 24977287 | ||
| Pubmed | The activity of TRAF RING homo- and heterodimers is regulated by zinc finger 1. | 9.37e-06 | 3 | 62 | 2 | 29176576 | |
| Pubmed | H4K20me0 marks post-replicative chromatin and recruits the TONSL–MMS22L DNA repair complex. | 9.37e-06 | 3 | 62 | 2 | 27338793 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 30127519 | ||
| Pubmed | Impaired recall of CD8 memory T cells in immunologically privileged tissue. | 9.37e-06 | 3 | 62 | 2 | 15661869 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 12586732 | ||
| Pubmed | The Structure and Ubiquitin Binding Properties of TRAF RING Heterodimers. | 9.37e-06 | 3 | 62 | 2 | 33539883 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 25996283 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 89876 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 291905 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 15039424 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 30591525 | ||
| Pubmed | Genetic variants associated with deep vein thrombosis: the F11 locus. | 9.37e-06 | 3 | 62 | 2 | 19583818 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 21629263 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 11971184 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 8999898 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 17475774 | ||
| Pubmed | B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. | 1.87e-05 | 4 | 62 | 2 | 10908663 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15121867 | ||
| Pubmed | EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. | 1.87e-05 | 4 | 62 | 2 | 25061874 | |
| Pubmed | Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation. | 1.87e-05 | 4 | 62 | 2 | 22593207 | |
| Pubmed | Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300. | 1.87e-05 | 4 | 62 | 2 | 30546087 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 19469909 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 9511754 | ||
| Pubmed | Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. | 1.87e-05 | 4 | 62 | 2 | 2844223 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 27797818 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 8555184 | ||
| Pubmed | Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway. | 1.87e-05 | 4 | 62 | 2 | 28759294 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 27641064 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 9685412 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 21268077 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 30892082 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 21822257 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 26381405 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 14506242 | ||
| Pubmed | 2.58e-05 | 95 | 62 | 4 | 20568250 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 2.83e-05 | 33 | 62 | 3 | 26864203 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 17912028 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 29478807 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 15965977 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 17332487 | ||
| Pubmed | TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer. | 3.12e-05 | 5 | 62 | 2 | 31262711 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 10523862 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 9990007 | ||
| Pubmed | TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression. | 3.12e-05 | 5 | 62 | 2 | 27818144 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 11882293 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 10962009 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 10075662 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 12372819 | ||
| Pubmed | RNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling. | 3.12e-05 | 5 | 62 | 2 | 29661858 | |
| Pubmed | The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis. | 3.12e-05 | 5 | 62 | 2 | 26153520 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.28e-05 | 101 | 62 | 4 | 23382219 | |
| Pubmed | 4.53e-05 | 533 | 62 | 7 | 25544563 | ||
| Pubmed | Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signaling. | 4.67e-05 | 6 | 62 | 2 | 21041727 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 19247373 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 11435475 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 20138174 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 11607847 | ||
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 4.67e-05 | 6 | 62 | 2 | 22615412 | |
| Pubmed | TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. | 4.67e-05 | 6 | 62 | 2 | 12296995 | |
| Pubmed | BAG6 negatively regulates the RLR signaling pathway by targeting VISA/MAVS. | 4.67e-05 | 6 | 62 | 2 | 36045679 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 11384837 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 18567820 | ||
| Pubmed | Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. | 4.67e-05 | 6 | 62 | 2 | 19937093 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 10025951 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 29228365 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 9275204 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 9852070 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 9022052 | ||
| Pubmed | Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. | 4.67e-05 | 6 | 62 | 2 | 16147974 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.88e-05 | 1201 | 62 | 10 | 35696571 | |
| Pubmed | 5.48e-05 | 41 | 62 | 3 | 20889853 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 27348524 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 23774506 | ||
| Pubmed | Identification of the MMS22L-TONSL complex that promotes homologous recombination. | 6.53e-05 | 7 | 62 | 2 | 21055984 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 9920895 | ||
| Pubmed | The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. | 6.53e-05 | 7 | 62 | 2 | 9774460 | |
| Pubmed | Purification and characterization of plasma protein C inhibitor. | 6.53e-05 | 7 | 62 | 2 | 2551064 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 10880535 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 14761960 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 9718306 | ||
| Pubmed | SNX5 inhibits RLR-mediated antiviral signaling by targeting RIG-I-VISA signalosome. | 6.53e-05 | 7 | 62 | 2 | 31806368 | |
| Interaction | NTN5 interactions | 9.50e-09 | 24 | 62 | 5 | int:NTN5 | |
| Interaction | IGFL3 interactions | 1.13e-07 | 75 | 62 | 6 | int:IGFL3 | |
| Interaction | FOXD4L6 interactions | 4.02e-07 | 49 | 62 | 5 | int:FOXD4L6 | |
| Interaction | ZFP41 interactions | 8.66e-07 | 57 | 62 | 5 | int:ZFP41 | |
| Interaction | FBN2 interactions | 1.68e-06 | 65 | 62 | 5 | int:FBN2 | |
| Interaction | FBXO2 interactions | 4.36e-06 | 411 | 62 | 9 | int:FBXO2 | |
| Interaction | TIMP3 interactions | 8.41e-06 | 90 | 62 | 5 | int:TIMP3 | |
| Interaction | TFPI2 interactions | 9.16e-06 | 43 | 62 | 4 | int:TFPI2 | |
| Interaction | ROBO4 interactions | 9.85e-06 | 14 | 62 | 3 | int:ROBO4 | |
| Interaction | EDN3 interactions | 2.04e-05 | 108 | 62 | 5 | int:EDN3 | |
| Interaction | CCN6 interactions | 2.59e-05 | 19 | 62 | 3 | int:CCN6 | |
| Interaction | PRG2 interactions | 2.66e-05 | 285 | 62 | 7 | int:PRG2 | |
| Interaction | ZNF224 interactions | 3.05e-05 | 20 | 62 | 3 | int:ZNF224 | |
| Interaction | TAFAZZIN interactions | 4.16e-05 | 207 | 62 | 6 | int:TAFAZZIN | |
| Interaction | DYRK1A interactions | 4.53e-05 | 552 | 62 | 9 | int:DYRK1A | |
| Interaction | GET1 interactions | 5.71e-05 | 68 | 62 | 4 | int:GET1 | |
| Interaction | TNFRSF11A interactions | 6.85e-05 | 26 | 62 | 3 | int:TNFRSF11A | |
| Interaction | ZNF408 interactions | 8.37e-05 | 145 | 62 | 5 | int:ZNF408 | |
| Interaction | TRAIP interactions | 9.29e-05 | 77 | 62 | 4 | int:TRAIP | |
| Interaction | NMS interactions | 1.06e-04 | 30 | 62 | 3 | int:NMS | |
| Interaction | STAT2 interactions | 1.13e-04 | 81 | 62 | 4 | int:STAT2 | |
| Interaction | ADAMTS9 interactions | 1.39e-04 | 6 | 62 | 2 | int:ADAMTS9 | |
| Interaction | SIRPD interactions | 1.43e-04 | 86 | 62 | 4 | int:SIRPD | |
| Interaction | NDP interactions | 1.69e-04 | 35 | 62 | 3 | int:NDP | |
| Interaction | GREM2 interactions | 2.00e-04 | 37 | 62 | 3 | int:GREM2 | |
| Interaction | POP1 interactions | 2.06e-04 | 277 | 62 | 6 | int:POP1 | |
| Interaction | NTRK2 interactions | 2.08e-04 | 176 | 62 | 5 | int:NTRK2 | |
| Interaction | TRAF3 interactions | 2.10e-04 | 278 | 62 | 6 | int:TRAF3 | |
| Cytoband | 4q35 | 1.86e-04 | 15 | 62 | 2 | 4q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p12 | 2.37e-03 | 53 | 62 | 2 | chr1p12 | |
| GeneFamily | TNF receptor associated factors | 8.97e-05 | 7 | 38 | 2 | 1056 | |
| GeneFamily | Low density lipoprotein receptors | 3.31e-04 | 13 | 38 | 2 | 634 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.68e-03 | 29 | 38 | 2 | 782 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.14e-03 | 394 | 38 | 4 | 471 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 7.89e-06 | 200 | 62 | 6 | M8506 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 4.64e-05 | 166 | 62 | 5 | M2398 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 4.84e-05 | 276 | 62 | 6 | M3063 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN | 6.01e-05 | 287 | 62 | 6 | M40958 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_UP | 7.69e-05 | 95 | 62 | 4 | M17083 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP | 8.01e-05 | 96 | 62 | 4 | M5549 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 8.79e-05 | 190 | 62 | 5 | MM1311 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 1.04e-04 | 197 | 62 | 5 | M7403 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.07e-04 | 198 | 62 | 5 | M7610 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP | 1.07e-04 | 198 | 62 | 5 | M4478 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 1.09e-04 | 199 | 62 | 5 | M9031 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 1.12e-04 | 200 | 62 | 5 | M7031 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 1.12e-04 | 200 | 62 | 5 | M7841 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 1.12e-04 | 200 | 62 | 5 | M7289 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN | 1.12e-04 | 200 | 62 | 5 | M7305 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 1.12e-04 | 200 | 62 | 5 | M7417 | |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP | 1.17e-04 | 40 | 62 | 3 | M41068 | |
| Coexpression | KONDO_EZH2_TARGETS | 2.10e-04 | 229 | 62 | 5 | M5301 | |
| Coexpression | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP | 2.15e-04 | 49 | 62 | 3 | M2202 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-07 | 162 | 62 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 145 | 62 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 160 | 62 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 160 | 62 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 169 | 62 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 184 | 62 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 184 | 62 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 184 | 62 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 139 | 62 | 4 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 139 | 62 | 4 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 139 | 62 | 4 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 139 | 62 | 4 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 156 | 62 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 162 | 62 | 4 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 163 | 62 | 4 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-05 | 171 | 62 | 4 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | Tuft-tuft-4|World / Class top | 1.01e-04 | 174 | 62 | 4 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 178 | 62 | 4 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 180 | 62 | 4 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.18e-04 | 181 | 62 | 4 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 183 | 62 | 4 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 183 | 62 | 4 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 183 | 62 | 4 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 184 | 62 | 4 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 186 | 62 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-04 | 186 | 62 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 187 | 62 | 4 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 187 | 62 | 4 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 62 | 4 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 187 | 62 | 4 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 187 | 62 | 4 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 188 | 62 | 4 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 188 | 62 | 4 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 188 | 62 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 189 | 62 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 189 | 62 | 4 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 191 | 62 | 4 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 191 | 62 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.48e-04 | 192 | 62 | 4 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 193 | 62 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-04 | 193 | 62 | 4 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-04 | 193 | 62 | 4 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-04 | 193 | 62 | 4 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 193 | 62 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 1.54e-04 | 194 | 62 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.54e-04 | 194 | 62 | 4 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 195 | 62 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 195 | 62 | 4 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-04 | 198 | 62 | 4 | e4cbe4032dba0da3fd46817ea9ad86ba9217f747 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.66e-04 | 198 | 62 | 4 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 77 | 62 | 3 | 7bb18406d404c51ee938cc577c155dc51868ddb9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 77 | 62 | 3 | ac311740424ff75b478b3c19fa0fae93776eb54e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 77 | 62 | 3 | 9f2dbf922acb905d636427a766a217c0db9671d2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.13e-07 | 155 | 62 | 7 | 6817_DN | |
| Drug | nickel hydroxide | 6.56e-06 | 259 | 62 | 7 | CID000025500 | |
| Drug | Epirubicin | 8.14e-06 | 47 | 62 | 4 | ctd:D015251 | |
| Drug | 2-vinyl benzaldehyde | 1.14e-05 | 108 | 62 | 5 | CID000039391 | |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.38e-05 | 192 | 62 | 6 | 5955_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.55e-05 | 196 | 62 | 6 | 2560_UP | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.11e-07 | 55 | 62 | 5 | C0079744 | |
| Disease | breast carcinoma (is_implicated_in) | 2.16e-07 | 25 | 62 | 4 | DOID:3459 (is_implicated_in) | |
| Disease | sunburn | 5.08e-05 | 96 | 62 | 4 | EFO_0003958 | |
| Disease | mosquito bite reaction size measurement | 8.47e-05 | 212 | 62 | 5 | EFO_0008378 | |
| Disease | factor XI measurement | 1.21e-04 | 8 | 62 | 2 | EFO_0004694 | |
| Disease | triacylglycerol 58:6 measurement | 1.21e-04 | 8 | 62 | 2 | EFO_0010440 | |
| Disease | Squamous cell carcinoma | 1.37e-04 | 124 | 62 | 4 | C0007137 | |
| Disease | type 1 diabetes mellitus | 1.57e-04 | 242 | 62 | 5 | MONDO_0005147 | |
| Disease | alopecia areata | 1.61e-04 | 50 | 62 | 3 | EFO_0004192 | |
| Disease | Bladder Neoplasm | 2.19e-04 | 140 | 62 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.25e-04 | 141 | 62 | 4 | C0005684 | |
| Disease | cryptorchidism (biomarker_via_orthology) | 2.36e-04 | 11 | 62 | 2 | DOID:11383 (biomarker_via_orthology) | |
| Disease | word reading | 3.52e-04 | 65 | 62 | 3 | EFO_0005300 | |
| Disease | breast carcinoma (is_marker_for) | 3.68e-04 | 66 | 62 | 3 | DOID:3459 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.30e-04 | 301 | 62 | 5 | DOID:684 (is_marker_for) | |
| Disease | autoimmune disease | 4.88e-04 | 173 | 62 | 4 | EFO_0005140 | |
| Disease | Leukemia, Myelocytic, Acute | 4.88e-04 | 173 | 62 | 4 | C0023467 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 6.34e-04 | 328 | 62 | 5 | EFO_0008377, EFO_0008378 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 6.50e-04 | 18 | 62 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | macula measurement | 6.81e-04 | 189 | 62 | 4 | EFO_0008375 | |
| Disease | glomerulonephritis (is_marker_for) | 7.26e-04 | 19 | 62 | 2 | DOID:2921 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.65e-04 | 195 | 62 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 7.72e-04 | 85 | 62 | 3 | C1510586 | |
| Disease | eosinophil percentage of leukocytes | 9.45e-04 | 746 | 62 | 7 | EFO_0007991 | |
| Disease | asthma | 9.82e-04 | 751 | 62 | 7 | MONDO_0004979 | |
| Disease | eosinophil count | MED24 MDN1 PLXNC1 TNFRSF8 LPP FAM76B ITGA6 HABP2 EXOC2 NOTCH2 | 1.01e-03 | 1488 | 62 | 10 | EFO_0004842 |
| Disease | Disorder of eye | 1.04e-03 | 212 | 62 | 4 | C0015397 | |
| Disease | Squamous cell carcinoma of esophagus | 1.07e-03 | 95 | 62 | 3 | C0279626 | |
| Disease | partial thromboplastin time | 1.16e-03 | 24 | 62 | 2 | EFO_0004310 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.22e-03 | 221 | 62 | 4 | C0011860 | |
| Disease | non-Hodgkins lymphoma | 1.26e-03 | 25 | 62 | 2 | EFO_0005952 | |
| Disease | neurotic disorder | 1.27e-03 | 101 | 62 | 3 | EFO_0004257 | |
| Disease | cancer | 1.53e-03 | 400 | 62 | 5 | MONDO_0004992 | |
| Disease | Hodgkins lymphoma, multiple myeloma, chronic lymphocytic leukemia | 1.59e-03 | 28 | 62 | 2 | EFO_0000095, EFO_0000183, EFO_0001378 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 1.59e-03 | 28 | 62 | 2 | DOID:3083 (biomarker_via_orthology) | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 1.62e-03 | 110 | 62 | 3 | EFO_0803335 | |
| Disease | estradiol measurement | 1.62e-03 | 110 | 62 | 3 | EFO_0004697 | |
| Disease | antipsychotic drug use measurement | 1.70e-03 | 29 | 62 | 2 | EFO_0007792 | |
| Disease | prostate cancer (is_implicated_in) | 1.94e-03 | 117 | 62 | 3 | DOID:10283 (is_implicated_in) | |
| Disease | chronic lymphocytic leukemia | 2.03e-03 | 119 | 62 | 3 | EFO_0000095 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.07e-03 | 32 | 62 | 2 | DOID:10155 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CQCRNANCSLPSCQK | 1746 | Q09472 | |
| SCCEEQNKVNCLQTR | 191 | P43652 | |
| QANQEKVLCCVSVCQ | 221 | P08910 | |
| NGQCVDKVNRFQCLC | 506 | Q04721 | |
| AQACLRRCSKNQQPQ | 2951 | Q9NU22 | |
| LQIAANQCCPECVLR | 76 | Q86XX4 | |
| VAQCFTAQCQPLFCN | 186 | Q86XX4 | |
| CPDDQFKCQNNRCIP | 886 | Q9NZR2 | |
| VNEKNLLSCCKNQCP | 756 | Q6ZNB6 | |
| GECPFNCNQKVKLRC | 786 | Q6ZNB6 | |
| CIVCCQSQNPNAYLN | 1006 | Q6ZRQ5 | |
| PEVVLNLFNCKNCAN | 41 | Q9UN88 | |
| SMKNCFQLLCNCQVP | 6 | Q9Y234 | |
| NCCRQGTVCLQIQME | 181 | A6NEK1 | |
| FRCASGQCVLIKQQC | 1341 | O75197 | |
| LCFNCCIAEQPQPKR | 6 | Q9NRR3 | |
| CQRIFQVNAPINCVC | 121 | Q9BVC4 | |
| FNTCTECKNQVCNLC | 1076 | Q9Y6V0 | |
| CQNKSQPNRTCTCSI | 546 | O60486 | |
| SLPCQFEQCIVCSLQ | 616 | Q96KP1 | |
| CFTCIICNNKLRGQP | 441 | Q93052 | |
| LVCAVAVRNCLECQQ | 1446 | P50851 | |
| QTCEQCKQQCAFDRK | 101 | Q5HYJ3 | |
| NCSVNVNCVNIRCPL | 966 | P23229 | |
| ENAVCAAQNCQRPCK | 1606 | P29375 | |
| IVAQRASQCLKQDCC | 321 | Q15646 | |
| NKCQKVQNTCKDNPC | 106 | Q14520 | |
| NCQKLTKIICAQQCS | 206 | P00533 | |
| CQKDRCCQSNCKLQP | 421 | Q9UKF2 | |
| TCRNVYNCELPQNCK | 1726 | Q9P2N4 | |
| RCIFKAIQCNDINPQ | 1716 | Q9H799 | |
| CNTTDRNAICVNCIK | 856 | Q86XK2 | |
| PCRAGCFVCRQSKQQ | 346 | Q8TCT0 | |
| QELQKICTCSPQQFN | 251 | Q5T5N4 | |
| ACQKLCTNAVRCQFF | 316 | P03951 | |
| ICQDTNQVLFKCCQG | 326 | Q9H9L4 | |
| ECQKRCTNNIRCQFF | 136 | P03952 | |
| QIQCRLPLQQCCVKG | 6 | Q5T749 | |
| CSPRARQFQPQCQVC | 66 | Q8TB03 | |
| ECAQNPLLCAFRCMN | 2256 | P35556 | |
| DACQRKPCQNNASCI | 351 | Q8NFT8 | |
| LRQNNSFLCLPCNCD | 836 | O75445 | |
| CVSCCLQPNKQLLLE | 131 | Q9H741 | |
| CVKQENTCLRNQYRC | 1071 | Q92673 | |
| NCDCTNFLLQECGKQ | 356 | O75448 | |
| QCLFQPVQCSNEKCR | 131 | O00463 | |
| EQQELFCQKLQQCCI | 66 | Q15172 | |
| PCQKQACEIQKCLQA | 6 | P56277 | |
| CFRRNVIQCDPRQCK | 1451 | O75443 | |
| KLCQICQNPFCEPVF | 816 | Q8WUH2 | |
| DRNSCQCVCKNKLFP | 311 | P49767 | |
| RTQNTKCRCKPNFFC | 121 | P25445 | |
| APCFQKALSCAQQAQ | 411 | Q96HA7 | |
| QNCPLANVICEYCNT | 206 | Q9Y4K3 | |
| CVIDKVTRNQCQECR | 151 | P10828 | |
| QNFCEKFCQCNPDCQ | 541 | Q92800 | |
| NRFPGCRCKTQCNTK | 556 | Q92800 | |
| AKPLQCEVCGFQCRQ | 521 | Q8N554 | |
| QQCPQRPTDCRKQCE | 56 | P28908 | |
| LQDCVQSFPCCQNMK | 356 | P37288 | |
| NQCLFTNTQCKVCCA | 66 | Q9UL40 | |
| QCINCEKIQHAQQTC | 61 | Q96PM5 | |
| NQITAERKVCNCCSQ | 91 | Q96NL1 | |
| LCLRCQQPTCQTKQA | 911 | Q5FWF4 | |
| FRCNINCDEDPKNCI | 36 | P17050 |